METTL14 causes the occurrence and development of leukemia by modifying MYB/MYC-targeted genes with m6A RNA, and m6A promotes the translation of c-MYC, BCL2, and PTEN in leukemia patients [24]. Here, BCL2 is linked to leukemia.